{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:33:52Z","timestamp":1793144032939,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jcv.2015.11.020","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T02:50:03Z","timestamp":1447815003000},"page":"S62-S68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"S1","title":["Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none"],"prefix":"10.1016","volume":"76","author":[{"given":"Mariam","family":"El-Zein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsay","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2015.11.020_bib0005","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/j.vaccine.2007.11.069","article-title":"Cervical cancer screening following prophylactic human papillomavirus vaccination","volume":"26","author":"Franco","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.11.020_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/14737159.2014.865521","article-title":"Cobas 4800HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens","volume":"14","author":"Isidean","year":"2014","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"Suppl. 5","key":"10.1016\/j.jcv.2015.11.020_bib0015","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.11.020_bib0020","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2015.11.020_bib0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.arcmed.2009.06.003","article-title":"The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change","volume":"40","author":"Franco","year":"2009","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.jcv.2015.11.020_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/rmv.1824","article-title":"Recent progress in vaccination against human papillomavirus-mediated cervical cancer","volume":"25","author":"McKee","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0035","first-page":"47","article-title":"9\u2014A broader HPV vaccine","volume":"57","author":"Gardasil","year":"2015","journal-title":"Med. Lett. Drugs Ther."},{"key":"10.1016\/j.jcv.2015.11.020_bib0040","first-page":"426485","article-title":"FDA approves new upgraded Gardasil 9","volume":"2045","author":"Kirby","year":"2014","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4161\/hv.5.10.9518","article-title":"Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years","volume":"5","author":"Einstein","year":"2009","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.jcv.2015.11.020_bib0050","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S1470-2045(14)71179-9","article-title":"Next generation prophylactic human papillomavirus vaccines","volume":"16","author":"Schiller","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0055","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/jcm4040614","article-title":"Safety and efficacy data on vaccines and immunization to human papillomavirus","volume":"4","author":"Kash","year":"2015","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jcv.2015.11.020_bib0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/14740338.2015.1013532","article-title":"Safety of human papillomavirus vaccines: a review","volume":"14","author":"Stillo","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jcv.2015.11.020_bib0065","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination reccomendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.jcv.2015.11.020_bib0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial Neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2015.11.020_bib0075","doi-asserted-by":"crossref","first-page":"g7584","DOI":"10.1136\/bmj.g7584","article-title":"Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model","volume":"350","author":"Jit","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jcv.2015.11.020_bib0080","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1016\/j.vaccine.2014.07.099","article-title":"Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study","volume":"32","author":"Laprise","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.11.020_bib0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/14760584.2015.964213","article-title":"Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs","volume":"14","author":"Isidean","year":"2015","journal-title":"Expert Rev. Vaccines"},{"issue":"Suppl. 5","key":"10.1016\/j.jcv.2015.11.020_bib0090","doi-asserted-by":"crossref","first-page":"F139","DOI":"10.1016\/j.vaccine.2012.05.039","article-title":"Human papillomavirus vaccine introduction-the first five years","volume":"30","author":"Markowitz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.11.020_bib0095","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(14)70481-4","article-title":"Present status of human papillomavirus vaccine development and implementation","volume":"16","author":"Herrero","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2015.11.020_bib0105","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2015.11.020_bib0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12325-015-0178-4","article-title":"Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review","volume":"32","author":"Mariani","year":"2015","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jcv.2015.11.020_bib0115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis","volume":"12","author":"Malag\u00f3n","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2015.11.020_bib0120","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt460","article-title":"Early impact of human papillomavirus vaccination on cervical neoplasia\u2014nationwide follow-up of young danish women","volume":"106","author":"Baldur-Felskov","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.11.020_bib0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/cit436","article-title":"Strongly decreased risk of genital warts after vaccination against human papillomavirus: Nationwide follow-up of vaccinated and unvaccinated girls in Denmark","volume":"57","author":"Blomberg","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.11.020_bib0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jnci\/djt032","article-title":"Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study","volume":"105","author":"Leval","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.11.020_bib0135","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","article-title":"Fall in human papillomavirus prevalence following a national vaccination program","volume":"206","author":"Tabrizi","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2015.11.020_bib0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2012.10.092","article-title":"Impact of human papillomavirus (HPV) vaccination on HPV 16\/18-related prevalence in precancerous cervical lesions","volume":"31","author":"Powell","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.11.020_bib0145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1200\/JCO.2013.52.4645","article-title":"Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada","volume":"32","author":"Mahmud","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0150","first-page":"1156","article-title":"approves Gardasil 9 for more types of HPV","author":"FDA","year":"2015","journal-title":"Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.jcv.2015.11.020_bib0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.vaccine.2006.05.061","article-title":"Chapter 20: issues in planning cervical cancer screening in the era of HPV vaccination","volume":"24","author":"Franco","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.11.020_bib0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"16","author":"Saslow","year":"2012","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.jcv.2015.11.020_bib0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"a Katki","year":"2011","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0180","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/ijc.23339","article-title":"Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study","volume":"122","author":"Cuzick","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.020_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.12.033","article-title":"HPV testing with cytology triage for cervical cancer screening in routine practice","volume":"210","author":"Louvanto","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0190","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncy.21544","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0195","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0200","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/ijc.29290","article-title":"Triaging HPV-positive women with normal cytology by p16\/Ki-67 dual-stained cytology testing: Baseline and longitudinal data","volume":"136","author":"Uijterwaal","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.020_bib0205","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2015.06.040","article-title":"A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results","volume":"138","author":"Schiffman","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","article-title":"Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial","volume":"15","author":"Verhoef","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0215","doi-asserted-by":"crossref","first-page":"E638","DOI":"10.1002\/ijc.29196","article-title":"Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16","volume":"136","author":"Louvanto","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jcv.2015.11.020_bib0220","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/cam4.473","article-title":"Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections","volume":"4","author":"Depuydt","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.jcv.2015.11.020_bib0225","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcv.2015.11.020_bib0230","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.vaccine.2014.01.087","article-title":"Does the HPV vaccination programme have implications for cervical screening programmes in the UK?","volume":"32","author":"Beer","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jcv.2015.11.020_bib0235","doi-asserted-by":"crossref","first-page":"e0134185","DOI":"10.1371\/journal.pone.0134185","article-title":"The participation of HPV-vaccinated women in a National cervical screening program: population-based cohort study","volume":"10","author":"Herweijer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2015.11.020_bib0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ypmed.2015.04.014","article-title":"Sobering realizations in cancer prevention and screening and their lessons","volume":"76","author":"Franco","year":"2015","journal-title":"Prev Med. (Baltim)"},{"key":"10.1016\/j.jcv.2015.11.020_bib0245","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/ije\/dyu140","article-title":"Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials","volume":"44","author":"Saquib","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0250","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jcv.2015.11.020_bib0255","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMp1401875","article-title":"Abolishing mammography screening programs? A view from the Swiss medical board","volume":"370","author":"Biller-Andorno","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2015.11.020_bib0260","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0361-090X(02)00118-6","article-title":"Evidence-based policy recommendations on cancer screening and prevention","volume":"26","author":"Franco","year":"2002","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.jcv.2015.11.020_bib0265","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ypmed.2015.01.035","article-title":"The significantly lower risk of cervical cancer at and after the recommended age to begin and end screening compared to breast and colorectal cancer","volume":"76","author":"Whitham","year":"2015","journal-title":"Prev. Med. (Baltim)"},{"key":"10.1016\/j.jcv.2015.11.020_bib0270","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2007.07.049","article-title":"Risk assessment to guide the prevention of cervical cancer","volume":"197","author":"Castle","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jcv.2015.11.020_bib0275","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/ije\/dyu267","article-title":"Commentary: screening: a seductive paradigm that has generally failed us","volume":"44","author":"G\u00f8tzsche","year":"2015","journal-title":"Int. J. Epidemiol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215007544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T12:53:36Z","timestamp":1537188816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653215007544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":55,"alternative-id":["S1386653215007544"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2015.11.020","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2015.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}